- Home
- HSBC vs BSX Comparison
HSBC vs BSX Comparison
Compare HSBC & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSBC
- BSX
- Stock Information
- Founded
- HSBC 1865
- BSX 1979
- Country
- HSBC United Kingdom
- BSX United States
- Employees
- HSBC N/A
- BSX N/A
- Industry
- HSBC Savings Institutions
- BSX Medical/Dental Instruments
- Sector
- HSBC Finance
- BSX Health Care
- Exchange
- HSBC Nasdaq
- BSX Nasdaq
- Market Cap
- HSBC 154.9B
- BSX 133.1B
- IPO Year
- HSBC N/A
- BSX 1992
- Fundamental
- Price
- HSBC $46.13
- BSX $91.46
- Analyst Decision
- HSBC Hold
- BSX Strong Buy
- Analyst Count
- HSBC 1
- BSX 23
- Target Price
- HSBC N/A
- BSX $93.73
- AVG Volume (30 Days)
- HSBC 1.2M
- BSX 6.6M
- Earning Date
- HSBC 10-29-2024
- BSX 10-23-2024
- Dividend Yield
- HSBC 4.33%
- BSX N/A
- EPS Growth
- HSBC N/A
- BSX 47.19
- EPS
- HSBC 1.20
- BSX 1.21
- Revenue
- HSBC $57,970,000,000.00
- BSX $15,911,000,000.00
- Revenue This Year
- HSBC N/A
- BSX $17.61
- Revenue Next Year
- HSBC N/A
- BSX $12.32
- P/E Ratio
- HSBC $7.22
- BSX $74.58
- Revenue Growth
- HSBC N/A
- BSX 15.66
- 52 Week Low
- HSBC $36.93
- BSX $53.93
- 52 Week High
- HSBC $47.56
- BSX $91.08
- Technical
- Relative Strength Index (RSI)
- HSBC 56.77
- BSX 67.55
- Support Level
- HSBC $45.64
- BSX $86.01
- Resistance Level
- HSBC $46.58
- BSX $91.08
- Average True Range (ATR)
- HSBC 0.49
- BSX 1.49
- MACD
- HSBC 0.01
- BSX 0.32
- Stochastic Oscillator
- HSBC 63.29
- BSX 90.97
About HSBC HSBC Holdings plc.
Established in 1865 in Hong Kong, London-based HSBC is one of the largest banks in the world, with assets of USD 3 trillion and 40 million customers worldwide. It operates across 64 countries with around 220,000 full-time staff. Key regions include Asia, Europe, the Middle East and North Africa, and North America. The United Kingdom and Hong Kong are the two largest markets for the bank. The bank offers retail, commercial and institutional banking, global banking and markets, wealth management, and private banking.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.